DNA vaccine production. Technician holding a bottle containing genetically modified (GM) bacteria used to produce recombinant hepatitis B vaccine. Traditional hepatitis vaccine contains the full virus, which could potentially become active and infect patients. A recombinant vaccine is made by inserting a piece of DNA from the virus into another organism, such as a bacterium. The viral protein is expressed by the bacterium and purified for use as a vaccine. Because the vaccine only contains a viral protein and not the whole virus, there is no risk of the virus becoming active. Photographed at Shantha Biotechnics in Hyderabad, India.
Model release not available. Property release not required.